A1 Refereed original research article in a scientific journal

Nuclear talin-1 provides a bridge between cell adhesion and gene expression




AuthorsDa Silva, Alejandro J.; Hästbacka, Hendrik S. E.; Puustinen, Mikael C.; Pessa, Jenny C.; Luoto, Jens C.; Sundström, Erika; Goult, Benjamin T.; Jacquemet, Guillaume; Henriksson, Eva; Sistonen, Lea

PublisherCell Press

Publishing placeCAMBRIDGE

Publication year2025

JournaliScience

Journal name in sourceiScience

Journal acronymISCIENCE

Article number111745

Volume28

Issue2

First page 111745

Number of pages18

ISSN2589-0042

eISSN2589-0042

DOIhttps://doi.org/10.1016/j.isci.2025.111745

Web address https://doi.org/10.1016/j.isci.2025.111745

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/485078218


Abstract
Talin-1 (TLN1) is best known to activate integrin receptors and transmit mechanical stimuli to the actin cytoskeleton at focal adhesions. However, the localization of TLN1 is not restricted to focal adhesions. By utilizing both subcellular fractionations and confocal microscopy analyses, we show that TLN1 localizes to the nucleus in several human cell lines, where it is tightly associated with the chromatin. Importantly, small interfering RNA (siRNA)-mediated depletion of endogenous TLN1 triggers extensive changes in the gene expression profile of human breast epithelial cells. To determine the functional impact of nuclear TLN1, we expressed a TLN1 fusion protein containing a nuclear localization signal. Our findings revealed that the accumulation of nuclear TLN1 alters the expression of a subset of genes and impairs the formation of cell-cell clusters. This study introduces an additional perspective on the canonical view of TLN1 subcellular localization and function.

Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Funding information in the publication
This work has been funded by the Research Council of Finland (338537 to G.J. and 355596 to L.S.), Sigrid Jusélius Foundation (G.J. and L.S.), Cancer Foundation Finland (G.J. and L.S.), Centre for International Mobility (A.J.D.S. and E.H.), Ella and Georg Ehrnrooth Foundation (A.J.D.S. and H.S.E.H.), Finnish Cultural Foundation (A.J.D.S.), K. Albin Johansson Foundation (A.J.D.S. and E.H.), InFLAMES Flagship Programme of the Research Council of Finland (decision numbers: 337530, 337531, 357910, and 357911 to G.J.), Magnus Ehrnrooth Foundation (A.J.D.S., J.C.L., and E.H.), Medicinska Understödsföreningen Liv och Hälsa r.f. (A.J.D.S., E.H., and L.S.), Otto A. Malm Foundation (A.J.D.S.), The Maud Kuistila Memorial Foundation (H.S.E.H.), Solutions for Health strategic funding to Åbo Akademi University (G.J.), and Åbo Akademi University (A.J.D.S., J.C.P., and L.S.).


Last updated on 2025-14-03 at 11:49